AYTU BIOSCIENCE, INC Contracts & Agreements

Amended and Restated Employment Agreement by and between Aytu BioPharma, Inc. and Ryan J. Selhorn dated November 11, 2024 (Filed With SEC on November 13, 2024)

Amended and Restated Employment Agreement by and between Aytu BioPharma, Inc. and Jarrett T. Disbrow dated March 20, 2023 (Filed With SEC on September 26, 2024)

Consent, Joinder and Amendment No. 5 to Loan and Security Agreement dated June 12, 2024, between the Company, the Obligors and lenders party thereto and Eclipse Business Capital... (Filed With SEC on June 18, 2024)

Term Loan Note dated June 12, 2024 (Filed With SEC on June 18, 2024)

Second Amended and Restated Revolving Note dated June 12, 2024 (Filed With SEC on June 18, 2024)

Commercial Manufacturing Services Agreement, dated November 13, 2023, by and between Aytu BioPharma, Inc. and Halo Pharmaceutical, Inc (Filed With SEC on February 14, 2024)

Amended and Restated Employment Agreement by and between the Company and Joshua R. Disbrow dated February 13, 2023 (Filed With SEC on October 12, 2023)

Amended and Restated Employment Agreement by and between the Company and Mark Oki dated February 13, 2023 (Filed With SEC on October 12, 2023)

Sublease Agreement by and between the Company and AMT Manufacturing Solutions, LLC dated April 27, 2023 (Filed With SEC on October 12, 2023)

Commercial Lease Agreement dated June 10, 1999, between Walstib, L.P. and Pharmafab, Inc (Filed With SEC on October 12, 2023)

First Amendment to Lease dated September 1, 2002, between Walstib, L.P. and PFAB, LP (Filed With SEC on October 12, 2023)

Second Amendment to Lease dated September 4, 2003, between Teachers Insurance and Annuity Association of America and PFAB, LP (Filed With SEC on October 12, 2023)

Third Amendment to Lease dated October 1, 2003, Between TIAA and PFAB, LP (Filed With SEC on October 12, 2023)

Fourth Amendment to Lease dated May 1, 2009, between TIAA and Neos Therapeutics, LP (formerly PFAB, LP) (Filed With SEC on October 12, 2023)

Fifth Amendment to Lease dated April 5, 2010, between TIAA and Neos Therapeutics, LP (Filed With SEC on October 12, 2023)

Sixth Amendment to Lease dated August 14, 2013, between Riverside Business Green, LP and Neos Therapeutics, LP (Filed With SEC on October 12, 2023)

Amended and Restated Employment Agreement by and between the Company and Greg Pyszczymuka dated March 21, 2023 (Filed With SEC on October 12, 2023)

Form of Pre-Funded Warrant (Filed With SEC on June 5, 2023)

Form of Tranche A Warrant (Filed With SEC on June 5, 2023)

Form of Tranche B Warrant (Filed With SEC on June 5, 2023)

Form of Placement Agency Agreement (Filed With SEC on June 5, 2023)

Form of Securities Purchase Agreement (Filed With SEC on June 5, 2023)

Amendment No. 4 to Loan and Security Agreement by and among Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos Therapeutics Commercial, LLC,... (Filed With SEC on May 11, 2023)

Second Amendment to Loan Documents by and among Avenue Capital Management II L.P., certain lenders and Aytu BioPharma, Inc., dated March 24, 2023 (Filed With SEC on May 11, 2023)

Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (Filed With SEC on May 11, 2023)

Description of Securities (Filed With SEC on September 27, 2022)

Underwriting Agreement dated August 9, 2022 (Filed With SEC on August 10, 2022)

Form of Pre-Funded Warrant (Filed With SEC on August 10, 2022)

Form of Common Warrant (Filed With SEC on August 10, 2022)

Form of Indemnification Agreement (Filed With SEC on July 1, 2022)

Settlement and Termination of License Agreement between the Registrant and TRIS Pharma, Inc., dated May 12, 2022 (Filed With SEC on May 16, 2022)

Underwriting Agreement, dated as of March 2, 2022, by and between Aytu BioPharma, Inc. and Canaccord Genuity LLC (Filed With SEC on March 4, 2022)

Form of Prefunded Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)

Form of Common Stock Purchase Warrant (Filed With SEC on March 4, 2022)

Employment Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)

Restricted Stock Award Agreement between Aytu BioPharma, Inc. and Mark Oki, effective January 17, 2022 (Filed With SEC on February 14, 2022)

Loan and Security Agreement dated January 26, 2022 between the registrant and the Avenue Capital Lenders and Avenue Capital Agent (Filed With SEC on February 14, 2022)

Promissory Note, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)

Closing Certificate with respect to the July 1, 2021 Asset Purchase Agreement, dated September 29, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on November 15, 2021)

Asset Purchase Agreement, dated July 1, 2021 by and between Aytu BioPharma, Inc. and UAB Caerus Biotechnologies (Filed With SEC on September 28, 2021)

Termination Agreement, dated June 29, 2021 by and between Aytu BioPharma, Inc. and Avrio Genetics, LLC (Filed With SEC on September 28, 2021)

Controlled Equity OfferingSM Sales Agreement, dated June 4, 2021, by and between Aytu BioPharma, Inc. and Cantor Fitzgerald & Co (Filed With SEC on June 7, 2021)

Asset Purchase Agreement, dated April 12, 2021 (Filed With SEC on May 17, 2021)

Indemnification Agreement between Aytu BioPharma, Inc. and Gerald McLaughlin, dated March 19, 2021 (Filed With SEC on May 17, 2021)

Indemnification Agreement between Aytu BioPharma, Inc. and Beth P. Hecht, dated March 19, 2021 (Filed With SEC on May 17, 2021)

Termination and Transition Agreement between Aytu BioPharma, Inc. and Acerus Pharmaceuticals Corporation, dated March 31, 2021 (Filed With SEC on May 17, 2021)

Separation Agreement between Aytu BioPharma, Inc. and David A. Green, dated March 31, 2021 (Filed With SEC on May 17, 2021)

Second Amendment to Employment Agreement with Joshua R. Disbrow dated April 7, 2021 (Filed With SEC on May 17, 2021)

Employment Agreement between Aytu BioPharma, Inc. and Nathaniel Massari, dated April 12, 2021 (Filed With SEC on May 17, 2021)

Employment Agreement between Aytu BioPharma, Inc. and Christopher Brooke, dated April 12, 2021 (Filed With SEC on May 17, 2021)

Option and Exclusive License Agreement between Rumpus VEDS, LLC and Denovo Biopharma LLC, dated December 21, 2019 (Filed With SEC on May 17, 2021)

Exclusive License Agreement between Rumpus VEDS, LLC and Johns Hopkins University, dated December 20, 2019 (Filed With SEC on May 17, 2021)

EMPLOYMENT AGREEMENT (Filed With SEC on April 5, 2021)

Consent, Waiver and Sixth Amendment to Facility Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics, LP, Neos... (Filed With SEC on March 22, 2021)

Consent, Waiver and Amendment No. 1 to Loan and Security Agreement, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc., Neos Therapeutics Brands, LLC, Neos Therapeutics,... (Filed With SEC on March 22, 2021)

License Agreement with Avrio Genetics, LLC, dated January 20, 2020 (Filed With SEC on February 11, 2021)

Amended and Restated Underwriting Agreement, dated December 10, 2020, between Aytu BioScience, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on December 14, 2020)

Form of Underwriter Warrants (Filed With SEC on December 14, 2020)

Agreement and Plan of Merger, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neutron Acquisition Sub, Inc. and Neos Therapeutics, Inc (Filed With SEC on December 10, 2020)

Commitment Letter, dated as of December 10, 2020, by and between Aytu BioScience, Inc. and Neos Therapeutics, Inc (Filed With SEC on December 10, 2020)

Deerfield Consent Letter, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc. and the lenders party thereto (Filed With SEC on December 10, 2020)

Commitment Letter, dated as of December 10, 2020, by and among Aytu BioScience, Inc., Neos Therapeutics, Inc. and Encina Business Credit, LLC (Filed With SEC on December 10, 2020)

Form of Aytu Stockholder Voting Agreement (Filed With SEC on December 10, 2020)

Form of Neos Stockholder Voting Agreement (Filed With SEC on December 10, 2020)

Amended Employment Agreement with Joshua R. Disbrow dated July 1, 2020 (Filed With SEC on October 6, 2020)

Amended Employment Agreement with David A. Green dated July 1, 2020 (Filed With SEC on October 6, 2020)

Form of Wainwright Warrant (Filed With SEC on July 2, 2020)

Form of Restricted Stock Cancelation and Exchange Agreement (Filed With SEC on July 2, 2020)

Early Payment Agreement, dated May 29, 2020 (Filed With SEC on June 1, 2020)

Form of Warrant (Filed With SEC on March 20, 2020)

Form of Placement Agents Warrants (Filed With SEC on March 20, 2020)

Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 20, 2020)

Form of Pre-Funded Purchase Warrant (Filed With SEC on March 13, 2020)

Form of Placement Agents Warrants (Filed With SEC on March 13, 2020)

Form of Securities Purchase Agreement, dated March 10, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)

Form of Warrant (Filed With SEC on March 13, 2020)

Form of Placement Agents Warrants (Filed With SEC on March 13, 2020)

Form of Securities Purchase Agreement, dated March 12, 2020, by and between the Company and the Purchaser (Filed With SEC on March 13, 2020)

First Amendment to Merger Purchase Agreement, dated January 9, 2020 (Filed With SEC on January 15, 2020)

Waiver and Amendment to the July 29, 2019 Amended and Restated License and Supply Agreement (Filed With SEC on December 2, 2019)

Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 7, 2019)

Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

First Amendment to Asset Purchase Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Registration Rights Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Cerecor Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Security Holder Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Officer Voting Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Consent and Limited Waiver Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Transition Services Agreement, dated November 1, 2019 (Filed With SEC on November 4, 2019)

Form of Common Stock Purchase Warrant (Filed With SEC on October 15, 2019)

Placement Agency Agreement, dated October 11, 2019 (Filed With SEC on October 15, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 15, 2019)

Form of Registration Rights Agreement (Filed With SEC on October 15, 2019)

Asset Purchase Agreement, dated October 10, 2019 (Filed With SEC on October 15, 2019)

Form of Contingent Value Rights Agreement (Filed With SEC on September 18, 2019)

Agreement and Plan of Merger, dated as of September 12, 2019, by and among Aytu BioScience, Inc., Aytu Acquisition Sub, Inc. and Innovus Pharmaceuticals, Inc (Filed With SEC on September 18, 2019)

AMENDED AND RESTATED LICENSE AND SUPPLY AGREEMENT BETWEEN ACERUS PHARMACEUTICALS CORPORATION and AYTU BIOSCIENCE, INC. Dated as of July 29, 2019 (Filed With SEC on August 2, 2019)

Employment Agreement, effective April 16, 2019, between Aytu BioScience, Inc. and Joshua R. Disbrow (Filed With SEC on May 14, 2019)

Employment Agreement, effective April 16, 2019, between Aytu BioScience, Inc. and Jarrett T. Disbrow (Filed With SEC on May 14, 2019)

Lease amendment between Aytu BioScience, Inc. and Beta Investors Group, LLC (Filed With SEC on May 14, 2019)

Independent Contractor Services Agreement dated as of May 1, 2019, by and between Aytu BioScience, Inc. and Averaden, LLC (Filed With SEC on May 2, 2019)

Form of Amendment No. 1 to Securities Purchase Agreement, dated April 24, 2019 (Filed With SEC on April 26, 2019)

License, Development, Manufacturing and Supply Agreement dated November 2, 2018 between Aytu BioScience, Inc. and TRIS Pharma, Inc (Filed With SEC on February 7, 2019)

Exchange Agreement dated February 5, 2019 (Filed With SEC on February 7, 2019)

Form of Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock (Filed With SEC on February 7, 2019)

Form of Warrant (Filed With SEC on February 7, 2019)

Waiver of Blocker dated February 5, 2019 (Filed With SEC on February 7, 2019)

Promissory Note Issued to Armistice Capital dated November 29, 2018 (Filed With SEC on December 4, 2018)

Form of Warrant for Offering (Filed With SEC on October 3, 2018)

Warrant Agency Agreement between Aytu BioScience, Inc. and VStock Transfer, LLC (Filed With SEC on October 3, 2018)

Form of Underwriting Agreement (Filed With SEC on September 25, 2018)

Form of Warrant for Offering (Filed With SEC on September 25, 2018)

Form of Representatives Warrant (Filed With SEC on September 25, 2018)

License, Development and Commercialization Agreement between the Registrant (as assigned to it by Ampio/Vyrix) and Daewoong Pharmaceuticals Co., Ltd., effective as of August 23,... (Filed With SEC on September 6, 2018)

Voting Agreement between the Registrant and Ampio, dated April 21, 2015 (Filed With SEC on September 6, 2018)

Amended and Restated Exclusive License Agreement, dated June 11, 2018, between Aytu BioScience, Inc. and Magna Pharmaceuticals, Inc (Filed With SEC on September 6, 2018)

Form of Warrant Exercise Agreement (Filed With SEC on March 28, 2018)

Form of Underwriting Agreement by and between the Company and Joseph Gunnar & Co., LLC as representative of the several underwriters named therein (Filed With SEC on February 28, 2018)

Form of Warrant for Offering (Filed With SEC on February 27, 2018)

Employment Agreement, by and between Aytu BioScience, Inc. and David A. Green, effective December 18, 2017 (Filed With SEC on December 19, 2017)

Portions of this exhibit marked [*] are requestedto be treated confidentially. (Filed With SEC on August 31, 2017)

COMMON STOCK PURCHASE WARRANT AytuBioScience, INC. (Filed With SEC on August 16, 2017)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on August 16, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 16, 2017)

AYTU BIOSCIENCE, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 27, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on June 19, 2017)

ASSET PURCHASE AGREEMENT March 31, 2017 (Filed With SEC on May 11, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on April 18, 2017)

Form of Amended and Restated Underwriters’Warrant Agreement (Filed With SEC on March 1, 2017)

UNDERWRITING AGREEMENT Between AYTU BIOSCIENCE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters (Filed With SEC on November 2, 2016)

WARRANT AGENT AGREEMENT (Filed With SEC on November 2, 2016)

EXHIBIT A Form of Underwriter’s Warrant Agreement (Filed With SEC on November 2, 2016)

WARRANT AGENT AGREEMENT (Filed With SEC on October 25, 2016)

UNDERWRITING AGREEMENT Between AYTU BIOSCIENCE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters (Filed With SEC on October 11, 2016)

Form of Underwriter’s Warrant Agreement (Filed With SEC on October 11, 2016)

UNDERWRITING AGREEMENT Between AYTU BIOSCIENCE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters (Filed With SEC on September 21, 2016)

FIRST AMENDMENT TO WARRANT AGENT AGREEMENT (Filed With SEC on September 21, 2016)

Form of Underwriter’s Warrant Agreement (Filed With SEC on September 21, 2016)

PURCHASE AGREEMENT (Filed With SEC on July 28, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 28, 2016)

RESTRICTED STOCK AWARD AGREEMENT (Filed With SEC on July 13, 2016)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2016)

WARRANT AGENT AGREEMENT (Filed With SEC on May 6, 2016)

COMMON STOCK PURCHASE WARRANT For the Purchase of _________ Shares ofCommon Stock of AYTU BIOSCIENCE, INC (Filed With SEC on May 6, 2016)

UNDERWRITING AGREEMENT Between AYTU BIOSCIENCE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters (Filed With SEC on May 3, 2016)

LICENSE AND SUPPLY AGREEMENT BETWEEN ACERUS PHARMACEUTICALS SRL and AYTU BIOSCIENCE, INC. (Filed With SEC on April 25, 2016)

SUBSCRIPTION FOR COMMON SHARES (Filed With SEC on April 25, 2016)

UNDERWRITING AGREEMENT Between AYTU BIOSCIENCE, INC. and JOSEPH GUNNAR & CO., LLC as Representative of the Several Underwriters (Filed With SEC on April 25, 2016)

Form of Underwriter’s Warrant Agreement (Filed With SEC on April 25, 2016)

WARRANT AGENT AGREEMENT (Filed With SEC on April 25, 2016)

NAME OF SUBSCRIBER: ________________ AytuBioScience, Inc. SUBSCRIPTIONAGREEMENT (Filed With SEC on January 20, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 6, 2015)

MASTER SERVICES AGREEMENT (Filed With SEC on October 13, 2015)

ASSET PURCHASE AGREEMENT October 5, 2015 (Filed With SEC on October 7, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 7, 2015)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on July 24, 2015)

AYTU BIOSCIENCE, INC. STOCK WARRANT (Filed With SEC on July 24, 2015)

NOTE PURCHASE AGREEMENT (Filed With SEC on July 24, 2015)

Aytu BioScience 2015 Stock Option and Incentive Plan AYTU BIOSCIENCE, INC. 2015 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 1, 2015)

ASSET PURCHASE AGREEMENT (Filed With SEC on June 8, 2015)

MANUFACTURING AND SUPPLY AGREEMENT by and between ETHYPHARM S.A. and AMPIO PHARMACEUTICALS, INC. * * * TABLE OF CONTENTS (Filed With SEC on June 8, 2015)

DISTRIBUTION AGREEMENT DATED AS OF MARCH 1, 2012 BETWEEN AMPIO PHARMACEUTICALS, INC. AND FBM INDUSTRIA FARMACEUTICA, LTDA. (Filed With SEC on June 8, 2015)

*** CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH [***]. ACOMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE... (Filed With SEC on June 8, 2015)

SPONSORED RESEARCH AGREEMENT (Filed With SEC on June 8, 2015)

Sponsored Research Agreement Addendum No. 4 March 17, 2014 (Filed With SEC on June 8, 2015)

ASSETPURCHASE AGREEMENT May 20, 2015 (Filed With SEC on May 27, 2015)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on April 22, 2015)

CERTIFICATE OF MERGER OF ROSEWIND MERGER SUB L, INC. WITHAND INTO LUOXIS DIAGNOSTICS, INC. * * * * * * * (Filed With SEC on April 22, 2015)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on April 22, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on April 22, 2015)

***Text Omitted and Filed Separately with the Securities and Exchange Commission DISTRIBUTION AGREEMENT DATED AS OF MARCH 1, 2012 BETWEEN AMPIO PHARMACEUTICALS, INC. AND FBM... (Filed With SEC on April 22, 2015)

*** Text Omitted and Filed Separately with the Securities and Exchange Commission DISTRIBUTION AND LICENSE AGREEMENT (Filed With SEC on April 22, 2015)

PROMISSORY NOTE (Filed With SEC on April 22, 2015)

Ampio Pharmaceuticals, Inc. assubscriber April 16, 2015 ROSEWIND CORPORATION 16200 WCR18E, LOVELAND, CO 80537 PHONE ###-###-#### SUBSCRIPTION AGREEMENT FOR COMMON SHARES (Filed With SEC on April 22, 2015)

Category

Industry

Companies

Contracts

AYTU BIOSCIENCE, INC Contracts & Agreements